Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Depression × Mass Screening × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 8 Breast Neoplasms 8 Neoplasms 7 Colorectal Neoplasms 7 Lung Neoplasms 4 Uterine Cervical Dysplasia 2 Prostatic Neoplasms 2 Papillomavirus Infections 2 Pancreatic Neoplasms 2 HIV Infections 2 Gastrointestinal Neoplasms 2 the Rate of Participation in Screening for PBC 1 Warts 1 Venous Thromboembolism 1 Uterine Cervical Diseases 1 Urinary Bladder Neoplasms 1 Tinea 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Retinoblastoma 1 Radiation Injuries 1 Pulmonary Atelectasis 1 Postural Orthostatic Tachycardia Syndrome 1 Postoperative Complications 1 Pneumonia 1 Pancreatic carcinoma, familial 1 Pancreatic cancer, adult 1 Oncology Problem 1 Nevus 1

Interventions

Therapeutics 22 Psychiatric Rehabilitation 19 Surveys and Questionnaires 10 Cognitive Behavioral Therapy 10 Ketamine 8 Early Intervention, Educational 8 Psilocybin 7 Yoga 6 Saline Solution 6 Methods 6 Counseling 6 Mindfulness-Based Cognitive Therapy 5 Interviews as Topic 5 Esketamine 5 Behavior Therapy 5 Acupuncture Therapy 5 Psychosocial Intervention 4 Mindfulness 4 Exercise Therapy 4 Escitalopram 4 Educational Status 4 Control Groups 4 Standard of Care 3 Psychotherapy 3 Palliative Care 3 Niacin 3 Methylphenidate 3 Melatonin 3 Meditation 3 Hypnosis 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02273206 2020-03-12

PCM3

Clinical Directors Network

Phase NA Completed

802 enrolled 28 charts

Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡